Skip to content

Screener

Eligibility screening

A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP

Sponsored by Monte Rosa Therapeutics, IncStudy detailsClinicalTrials.gov

4 US sites in FL, KS, MO, TX

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.